Correction

Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease (Sep, 10.1038/s41409-020-01049-0, 2020)

Journal

BONE MARROW TRANSPLANTATION
Volume 56, Issue 5, Pages 1217-1217

Publisher

SPRINGERNATURE
DOI: 10.1038/s41409-020-01083-y

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available